Potential utility of a longitudinal relative dose intensity of molecularly targeted agents in phase 1 dose-finding trials-Reference-Cited by-同舟云学术

Potential utility of a longitudinal relative dose intensity of molecularly targeted agents in phase 1 dose-finding trials

Published:2017-12-08 Issue:1 Volume:109 Page:207-214
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Hirakawa Akihiro¹²^ORCID,Yonemori Kan²³⁴,Kinoshita Fumie⁵,Kobayashi Yumiko⁵,Okuma Hitomi S.²,Kawachi Asuka²,Tamura Kenji²^ORCID,Fujiwara Yasuhiro²,Rubinstein Larry⁶,Harris Pamela Jo⁴,Takebe Naoko⁴

Affiliation:

1. Department of Biostatistics and Bioinformatics; Graduate School of Medicine; The University of Tokyo; Tokyo Japan

2. Department of Breast and Medical Oncology; National Cancer Center Hospital; Tokyo Japan

3. Department of Experimental Therapeutics; National Cancer Center Hospital; Tokyo Japan

4. Investigational Drug Branch; Cancer Therapy Evaluation Program; Division of Cancer Treatment and Diagnosis; National Cancer Institute, National Institute of Health; Rockville MD USA

5. Statistical Analysis Section; Center for Advanced Medicine and Clinical Research; Nagoya University Hospital; Nagoya Japan

6. Biometric Research Program; Division of Cancer Treatment and Diagnosis; National Cancer Institute; National Institute of Health; Rockville MD USA

Funder

Japan Society for the Promotion of Science

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cas.13436/fullpdf

Reference29 articles.